This finding was also mirrored in cSCCs, suggesting that CDKN2A mutational presence in a metastatic tumor can predict the prognosis of metastatic cSCC and SCCs [68,70]. This evidence concerns the gene CDKN2A and skin squamous cell carcinoma.